Helios has entered into an agreement to acquire a majority stake in the largest and most diversified group of MedTech companies in Morocco. The consolidated group operates in medical devices, in vitro diagnostic and pharmaceuticals, and comprises four companies: Techniques Science Santé (“T2S”), IM Alliance, Cyclopharma and Binarios.

Cliquez ici pour télécharger